243 related articles for article (PubMed ID: 28976136)
41. A comprehensive salivary analysis for oral cancer diagnosis.
Shpitzer T; Bahar G; Feinmesser R; Nagler RM
J Cancer Res Clin Oncol; 2007 Sep; 133(9):613-7. PubMed ID: 17479291
[TBL] [Abstract][Full Text] [Related]
42. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
43. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
44. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
45. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
[TBL] [Abstract][Full Text] [Related]
46. Variations of salivary concentration of cytokines and chemokines in presence of oral squamous cell carcinoma. A case-crossover longitudinal prospective study.
Val M; Sidoti Pinto GA; Manini L; Gandolfo S; Pentenero M
Cytokine; 2019 Aug; 120():62-65. PubMed ID: 31005727
[TBL] [Abstract][Full Text] [Related]
47. Histone modification patterns correlate with patient outcome in oral squamous cell carcinoma.
Chen YW; Kao SY; Wang HJ; Yang MH
Cancer; 2013 Dec; 119(24):4259-67. PubMed ID: 24301303
[TBL] [Abstract][Full Text] [Related]
48. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M
Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445
[TBL] [Abstract][Full Text] [Related]
49. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
[TBL] [Abstract][Full Text] [Related]
50. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma.
Bagué S; León X; Terra X; Lejeune M; Camacho M; Avilés-Jurado FX
Head Neck; 2022 Nov; 44(11):2505-2512. PubMed ID: 36207788
[TBL] [Abstract][Full Text] [Related]
51. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma.
Agha-Hosseini F; Mirzaii-Dizgah I; Farmanbar N; Abdollahi M
J Oral Pathol Med; 2012 Nov; 41(10):736-40. PubMed ID: 22582895
[TBL] [Abstract][Full Text] [Related]
52. Estimation of Salivary and Serum Lactate Dehydrogenase in Oral Submucous Fibrosis.
Mishra S; Kritika C; Bajoria AA; Choudhury P; Sahoo SK; Sangamesh NC
J Int Soc Prev Community Dent; 2018; 8(4):289-295. PubMed ID: 30123759
[TBL] [Abstract][Full Text] [Related]
53. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions.
Bhattacharjee A; Giri S; Roy M; Chakraborty A
J Cancer Res Ther; 2018; 14(5):934-940. PubMed ID: 30197328
[TBL] [Abstract][Full Text] [Related]
54. Expression of Mucin1 in saliva in oral squamous cell carcinoma and oral potentially malignant disorders (case control study).
Abdelwhab A; Shaker O; Aggour RL
Oral Dis; 2023 May; 29(4):1487-1494. PubMed ID: 35080082
[TBL] [Abstract][Full Text] [Related]
55. Assessment of salivary total antioxidant capacity in patients with primary untreated head and neck squamous cell carcinoma with ORAC.
Wesołowski P; Zawada K; Wojtowicz A; Strużycka I; Kamiński T
J Oral Pathol Med; 2016 Nov; 45(10):753-757. PubMed ID: 26876359
[TBL] [Abstract][Full Text] [Related]
56. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.
Li SX; Yang YQ; Jin LJ; Cai ZG; Sun Z
Cancer Biomark; 2016; 17(4):377-382. PubMed ID: 27662323
[TBL] [Abstract][Full Text] [Related]
57. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
Liu CJ; Lin SC; Yang CC; Cheng HW; Chang KW
Head Neck; 2012 Feb; 34(2):219-24. PubMed ID: 22083872
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients.
Sivaramakrishnan M; Sivapathasundharam B; Jananni M
J Oral Pathol Med; 2015 Jul; 44(6):449-52. PubMed ID: 25224513
[TBL] [Abstract][Full Text] [Related]
59. Salivary Lactate Dehydrogenase (LDH)- A Novel Technique in Oral Cancer Detection and Diagnosis.
Lokesh K; Kannabiran J; Rao MD
J Clin Diagn Res; 2016 Feb; 10(2):ZC34-7. PubMed ID: 27042582
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.
Hoffmann RR; Yurgel LS; Campos MM
Regul Pept; 2011 Jan; 166(1-3):55-8. PubMed ID: 20727373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
